PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,630,012 | +2.5% | 94,003 | +7.2% | 0.00% | – |
Q2 2023 | $1,589,540 | -79.1% | 87,723 | -69.3% | 0.00% | -100.0% |
Q1 2023 | $7,593,342 | +244.6% | 285,464 | +150.5% | 0.00% | – |
Q4 2022 | $2,203,233 | -50.6% | 113,980 | -46.7% | 0.00% | -100.0% |
Q3 2022 | $4,464,000 | +56.6% | 213,693 | -40.0% | 0.00% | – |
Q2 2022 | $2,850,000 | +26.0% | 356,039 | +10.3% | 0.00% | – |
Q1 2022 | $2,262,000 | -51.2% | 322,764 | -5.9% | 0.00% | -100.0% |
Q4 2021 | $4,632,000 | +81.4% | 343,120 | +126.9% | 0.00% | – |
Q3 2021 | $2,554,000 | +160.1% | 151,245 | +348.9% | 0.00% | – |
Q2 2021 | $982,000 | +477.6% | 33,695 | +679.4% | 0.00% | – |
Q1 2021 | $170,000 | -22.0% | 4,323 | -55.0% | 0.00% | – |
Q4 2020 | $218,000 | -40.8% | 9,607 | -40.9% | 0.00% | – |
Q3 2020 | $368,000 | +569.1% | 16,256 | +856.2% | 0.00% | – |
Q2 2020 | $55,000 | – | 1,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |